Coronavirus Update: Gilead To Meet Global Remdesivir Demand By October
Plus: AstraZeneca Signs China Vaccine Deal
Ramp-up is possible thanks to increased internal capacity and network of voluntary licensing partners including Mylan, Cipla and Dr Reddy's.
